Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Trump picks ex-N. Korea policy official as his principal deputy national security adviser

    Trump picks ex-N. Korea policy official as his principal deputy national security adviser
  2. 2

    S. Korea not to attend Sado mine memorial: foreign ministry

    S. Korea not to attend Sado mine memorial: foreign ministry
  3. 3

    First snow to fall in Seoul on Wednesday

    First snow to fall in Seoul on Wednesday
  4. 4

    Man convicted after binge eating to avoid military service

    Man convicted after binge eating to avoid military service
  5. 5

    Wealthy parents ditch Korean passports to get kids into international school

    Wealthy parents ditch Korean passports to get kids into international school
  1. 6

    Toxins at 622 times legal limit found in kids' clothes from Chinese platforms

    Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
  2. 7

    [Weekender] Korea's traditional sauce culture gains global recognition

    [Weekender] Korea's traditional sauce culture gains global recognition
  3. 8

    BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'

    BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
  4. 9

    Korea to hold own memorial for forced labor victims, boycotting Japan’s

    Korea to hold own memorial for forced labor victims, boycotting Japan’s
  5. 10

    Nvidia CEO signals Samsung’s imminent shipment of AI chips

    Nvidia CEO signals Samsung’s imminent shipment of AI chips
피터빈트

[Photo News] KDDF partners with MSD for new drug development

By Sohn Ji-young

Published : June 8, 2016 - 13:46

    • Link copied

Korea Drug Development Fund CEO Joo Sang-aun (left) and Mathai Mammen, senior vice president of cardiovascular diseases, metabolic diseases, immunology and oncology at U.S.-based pharmaceutical company Merck Sharp & Dohme signed a memorandum of understanding Tuesday at the 2016 BIO International Convention taking place in San Francisco. The two have agreed to launch a new joint research and development program geared at linking Korea’s new drug development capabilities with global pharmaceutical companies, the KDDF said. (KDDF) Korea Drug Development Fund CEO Joo Sang-aun (left) and Mathai Mammen, senior vice president of cardiovascular diseases, metabolic diseases, immunology and oncology at U.S.-based pharmaceutical company Merck Sharp & Dohme signed a memorandum of understanding Tuesday at the 2016 BIO International Convention taking place in San Francisco. The two have agreed to launch a new joint research and development program geared at linking Korea’s new drug development capabilities with global pharmaceutical companies, the KDDF said. (KDDF)

More from Headlines